BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31363805)

  • 1. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
    Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in placental nitric oxide, but not nitric oxide-mediated relaxation, underlie the improvement in placental efficiency and antihypertensive effects of hydrogen sulphide donor in hypertensive pregnancy.
    Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1118-1127. PubMed ID: 29927503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.
    Possomato-Vieira JS; Gonçalves-Rizzi VH; Graça TU; Nascimento RA; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1325-1332. PubMed ID: 27620880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticontractile Effect of Perivascular Adipose Tissue But Not of Endothelium Is Enhanced by Hydrogen Sulfide Stimulation in Hypertensive Pregnant Rat Aortae.
    Souza-Paula E; Polonio LCC; Zochio GP; da Silva KP; Kushima H; Dias-Junior CA
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):715-729. PubMed ID: 32976209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antihypertension effect of hydrogen sulfide (H
    Zhu ML; Zhao FR; Zhu TT; Wang QQ; Wu ZQ; Song P; Xu J; Wan GR; Yin YL; Li P
    Life Sci; 2021 Feb; 267():118831. PubMed ID: 33253721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
    Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral Na
    Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
    Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
    Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
    Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy hypertension-associated endothelial dysfunction is attenuated by isoflurane anesthesia: Evidence of protective effect related to increases in nitric oxide.
    Rodrigues SD; da Silva MLS; Martins LZ; Gomes SEB; Mariani NAP; Silva EJR; Kushima H; Mattos BR; Rizzi E; Dias-Junior CA
    Life Sci; 2023 Oct; 331():122039. PubMed ID: 37648198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H
    Lu M; Jiang X; Tong L; Zhang F; Ma L; Dong X; Sun X
    Biol Pharm Bull; 2018 Feb; 41(2):229-238. PubMed ID: 29187695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide donor, NaHS, stimulates ANP secretion via the K
    Yu L; Park BM; Ahn YJ; Lee GJ; Kim SH
    Peptides; 2019 Jan; 111():89-97. PubMed ID: 29684589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
    Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
    PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
    Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
    Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H
    Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
    Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.
    Zhong G; Chen F; Cheng Y; Tang C; Du J
    J Hypertens; 2003 Oct; 21(10):1879-85. PubMed ID: 14508194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Experimental Evidences of Hydrogen Sulfide Involvement in Lead-Induced Hypertension.
    Possomato-Vieira JS; Gonçalves-Rizzi VH; do Nascimento RA; Wandekin RR; Caldeira-Dias M; Chimini JS; da Silva MLS; Dias-Junior CA
    Biomed Res Int; 2018; 2018():4627391. PubMed ID: 29789795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
    Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
    J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.